Oncology

Latest News

Tech Updates: McKesson Launches Precision Oncology Consortium; Financing for RISA Labs PA Platform

By Mary Caffrey

April 17th 2025

These advances are designed to improve uptake of biomarker-driven cancer care and reduce treatment delays.

Making Novel Cancer Therapies Available Requires Choices Because Resources Are Limited

By Kyle Munz

April 14th 2025

Businessman shows medical network wooden block for health, medicine, insurance, healthcare, care, concept. Medical technology services to solve public - ภัทรชัย รัตนชัยวงค์ - stock.adobe.com.jpeg

NCCN Data Find Racial, Socioeconomic Disparities in Quality of Care for Metastatic Pancreatic Cancer

By Giuliana Grossi

April 9th 2025

Comparing Breast Cancer Treatment Outcomes Between Fee-for-Service and Medicare Advantage

By Galen Shearn-Nance, BS
Rishi R. Sachdev, BS

April 4th 2025

Woman with keloid on shoulder | Image credit: weerajata – stock.adobe.com

Deep Learning Tool Differentiates Keloids From Malignant Lesions Without Dermoscopy

By Hayden E. Klein

April 2nd 2025

Join this expert panel to discuss precision medicine in NSCLC, current immunotherapies, and more.

Watch the series now!

Watch Now

Join a panel of leaders as they discuss treatment for patients diagnosed with metastatic NSCLC without driver mutations

More News

October 10th 2014

Velcade Approved For Treatment-NaÃ¯ve Mantle Cell Lymphoma Patients

The approval extends the use of bortezomib beyond relapsed and refractory patients.

October 9th 2014

Urine Test Could Diagnose Prostate Cancer

The identification of specific RNA molecules in the urine of individuals with prostate cancer raises hope for a non-invasive test for the disease.

October 8th 2014

Genentech Faces Backlash Following Onco-Specialty Decision

Having decided to restrict the distribution of 3 of its top-selling oncology medications, Avastin, Rituxan, and Herceptin only through specialty pharmacies, Genentech is witnessing protests in various forms from healthcare centers.

October 8th 2014

Episode 17 - Final Thoughts on the State of Medical Oncology

October 8th 2014

Episode 16 - Impact of Electronic Medical Records in Oncology Practices

October 8th 2014

Episode 15 - Quality Metrics and Patient-Reported Outcomes

October 8th 2014

Episode 14 - Quality Initiatives in Medical Oncology

October 8th 2014

Episode 13 - Patient-Centered Approach to Improve Quality

October 8th 2014

Episode 12 - Cost Considerations and Comparative Effectiveness Research

October 8th 2014

Episode 11 - The Importance of Patient Education

October 8th 2014

Episode 10 - Comparative Effectiveness Research

October 8th 2014

Episode 9 - Analyzing Incentive Programs

October 8th 2014

Episode 8 - Immunotherapy and Pathways: Safety Considerations

October 8th 2014

Episode 7 - Inclusion of Generic Drugs in Pathways

October 8th 2014

Episode 6 - Measuring the Success of Clinical Pathways

October 8th 2014

Episode 5 - Utilization of Clinical Pathways in Oncology

October 8th 2014

Episode 4 - Potential Impact of Data Integration Projects

October 8th 2014

Episode 3 - Examining Data Integration Platforms

October 8th 2014

Episode 2 - Gaps in Data Exchange From a Payer Perspective

October 8th 2014

Episode 1 - Evidence-Based Decisions for Data Generation, Collection, and Analysis

October 8th 2014

Collaboration Will Help Match the Right Patient With the Right Trial

The collaboration between med fusion and GenomOncology promises improved outcomes in personalized cancer trials.

October 7th 2014

In The Literature: TNF-Î± Antagonists in RA Patients Reduces Cancer Risk

A Taiwan study found a significantly reduced risk of cancer among RA patients on biologics.

October 7th 2014

Cancer and Mental Health

Results of a large study performed across cancer centers in Germany, published online October 6, 2014 in the Journal of Clinical Oncology, show that 32% of people with cancer experienced some form of clinically relevant mental health challenge, such as anxiety, depressive and adjustment disorders.

October 6th 2014

Dr Peter B. Bach Outlines Framework for Tying Price of Cancer Drugs to Indication, Value

Mary K. Caffrey

Peter B. Bach, MD, MAPP, Memorial Sloan Kettering Cancer Center, writes in the Journal of the American Medical Association that cancer drugs could be charged different prices by indication, since the value for patients varies. His article appeared days before an appearance on 60 Minutes to discuss the high price of cancer drugs.

October 6th 2014

BMS to Collaborate with Novartis to Test Nivolumab in NSCLC

Combining nivolumab, an immuno-oncology molecule, with 1 of 3 targeted agents from Novartis is expected to improve patient response in NSCLC.

October 6th 2014

Study Identifies Lapses in Safe Chemotherapy Administration

Chemotherapy drugs, which could be poisons, can result in adverse health outcomes in healthcare workers who administer them to patients without adequate safety measures.

October 6th 2014

Vosaroxin Fails in Phase 3 AML Trials in the Elderly

Sunesis Pharmaceuticals announced the failure of a phase 3 study Monday morning. The company's experimental drug vosaroxin did not extend survival of elderly patients with advanced acute myeloid leukemia compared to a placebo.

October 5th 2014

Avoid Unnecessary Pap Tests: Study Concludes

A study published in the American Journal of Preventive Medicine found that lack of awareness resulted in women over 65 and those who had undergone hysterectomy routinely undergoing a Pap test.

October 5th 2014

ASCO Provides Input on CMMI's

ASCO has been working in parallel with various other institutions to generate a patient-centered oncology payment reform model.

October 5th 2014

In The Literature: NSAID/Statin Influence on PSA in High-Risk Prostate Cancer Patients

The study, published in Cancer Epidemiology, Biomarkers & Prevention, evaluated the influence of NSAIDs and statins on PSA levels in men with a high prostate cancer risk.

...

148 149 150 151 152 153 154 155 156

...

184 >

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

Do Not Sell My Information

Terms & Conditions